Trial Profile
Role of Intravitreal Aflibercept Injection for the Treatment of Radiation Maculopathy
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 12 May 2021
Price :
$35
*
At a glance
- Drugs Aflibercept (Primary)
- Indications Retinal oedema
- Focus Therapeutic Use
- 17 Apr 2021 Status changed from active, no longer recruiting to completed.
- 05 Mar 2019 Planned End Date changed from 1 Dec 2016 to 1 Dec 2019.
- 05 Mar 2019 Status changed from not yet recruiting to active, no longer recruiting.